Added to YB: 2026-05-27
Pitch date: 2026-03-23
HIMS [bearish]
Hims & Hers Health, Inc.
-7.38%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$5.5B
Pitch Price
$22.21
Price Target
9.00 (-62%)
Dividend
N/A
EV/EBITDA
58.42
P/E
-406.55
EV/Sales
2.48
Sector
Health Care Providers and Services
Category
special_situation
Hims & Hers Health, Inc. - $HIMS (short)
HIMS (short): Rode GLP-1 compounding boom while violating patent law; core business (ED/hair loss) decelerated to MSD% growth in 4Q25 amid surging competition & CACs. New Novo partnership forces transition from ~$153 gross profit/unit compounded GLP-1s to branded at ~35% lower margin. 2026 guide backend-loaded (+24% growth Q2-Q4 vs +5% Q1) & requires Eucalyptus acquisition to plug organic shortfall. Estimate 4Q26 gross profit -15% vs consensus, 2027 EBITDA -20% below Street. 12x EV/EBITDA on base case = $14 (-38%); 10x downside case = $9 (-60%). Risks: meme stock, high short interest (40% float), mgmt obfuscation via M&A.
Read full article (6 min)